Rebopag 25mg Tablet, manufactured by MSN Laboratories, contains the active ingredient Eltrombopag. It is primarily used to treat low platelet counts in conditions such as chronic immune thrombocytopenic purpura (ITP), chronic hepatitis C virus (HCV) infection, and severe aplastic anemia. Eltrombopag acts as a thrombopoietin receptor agonist, stimulating the production of platelets in the bone marrow, thereby reducing the risk of bleeding associated with low platelet counts.